Management of Febrile Neutropenia in Leukemia Patients Undergoing Chemotherapy: The Roles of Nurses
Article Sidebar
Main Article Content
Abstract
Febrile neutropenia is a medical emergency of leukemia patients receiving chemotherapy. This condition arises when the white blood cell count in the body decreases, putting the body at a high risk of infection. The impact of febrile neutropenia on patients is significant, often leading to prolonged hospital stays, increased healthcare costs, a higher risk of complications such as septic shock, and an increase the risk of death. Nurses play a critical role in managing febrile neutropenia for leukemia patients undergoing chemotherapy. Such as a vigilant monitoring and assessment to detect this condition in a timely manner. Nurses are also responsible for implementing nursing practices that strictly focus on infection control and prevention. Effective drugs used administration is another crucial aspect of nursing care. In addition, nurses are responsible for educating and advising patients and their families to reduce the risk of developing febrile neutropenia. Moreover, nurses collaborate with other healthcare team members and provide mental support to ensure that patients receive holistic care. These roles combined efforts lead to more effective treatment, ensuring that patients can receive their scheduled chemotherapy on time, reducing hospital stays and healthcare costs, decreasing the risk of complications and mortality, and ultimately improving the quality of life for leukemia patients undergoing chemotherapy and their families.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. Clin Oncol 2018;36(14):1443-53. https://doi.org/10.1200/JCO.2017.77.6211
Ayaz CM, Hazırolan G, Sancak B, Hascelik G, Akova M. Factors associated with Gram-negative bacteremia and mortality in neutropenic patients with hematologic malignancies in a high-resistance setting. Infect Dis Clin Microbiol 2022;2:87-98. DOI:10.36519/idcm.2022.141
Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M et al. ESMO Guidelines Committee. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol 2016;27(suppl 5):v111-18. doi:10.1093/annonc/mdw325.PMID: 27664247.
Lekdamrongkul P. Nursing management and assessment of febrile neutropenia (FN) risks in cancer patients treated with chemotherapy: The role of nurses. Thai Journal of Nursing Council 2015;30(1):5-15. (in Thai)
Jamjumrus J, Chanpho, D. Roles of nurses in the prevention and management of the febrile neutropenia in cancer patients undergoing chemotherapy. Siriraj Med Bull 2021;14(3):61-5. http://dx.doi.org/10.33192/Simedbull.2021.28. (in Thai)
Ishikawa K, Masaki T, Kawai F, Ota E, Mori N. Systematic review of the short-term versus long-term duration of antibiotic management for neutropenic fever in patients with cancer. Cancers 2023;15(5):1611. https://doi.org/10.3390/cancers15051611
Hansen BA, Wendelbo Ø, Bruserud Ø, Hemsing AL, Mosevoll KA, Reikvam H. Febrile neutropenia in acute Leukemia. Epidemiology, etiology, pathophysiology and treatment. Mediterr J Hematol Infect Dis 2020;12(1):e2020009. doi:10.4084/MJHID.2020.009. PMID: 31934319; PMCID: PMC6951355.
Nakamanuruk W, Ritklar L. Development of nursing practice guidelines for the prevention of febrile neutropenia in patients undergoing chemotherapy. TUH Journal 2021;6(2):20-7. (in Thai)
Worapanwisit T, Paritsiraprapa C, Rotchanarak W. Prevention of febrile neutropenia in acute leukemia patients: role of nurse. JRTAN 2020;21(3):11-9. (in Thai)
Petpirin P. Nursing care for acute myeloblastic leukemia receiving hemotherapy: 2 case studies. Mahasarakham Hospital Journal 2018;15(3):178-86.
Flanigan JA, Yasuda M, Chen CC, Li EC. Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US. Support Care Cancer 2024;32:373. https://doi.org/10.1007/s00520-024-08492-5
Hughes JH, Tong DMH, Burns V, Daly B, Razavi P, Boelens JJ, et al. Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model. CPT Pharmacometrics Syst Pharmacol 2023;12(11):1764-76. doi:10.1002/psp4.13019
Potemski P, Krzakowski M. Supportive care neutropenia. Oncology. in Clinical Practice 2020;16(3):87-96. DOI:10.5603/OCP.2020.0009
Hanzelina H, Widnyana AANKP, Windiani IGAT, Karyana IPG, Ariawati NK, Mahalini DS. Malnutrition as risk factor for febrile neutropenia in children with acute lymphoblastic leukemia. Open Access Maced J Med Sci 2022;10(B):681-85. https://doi.org/10.3889/oamjms.2022.8448
Patel K, West H. Febrile Neutropenia. JAMA Oncol 2017;3(12):1751. doi:10.1001/jamaoncol.2017.1114
Rasmy A, Amal A, Fotih S, Selwi W et al. Febrile neutropenia in cancer patient: epidemiology,microbiology, pathophysiology and management. J Cancer Prev Curr Res 2016;5(3):273-78.DOI:10.15406/jcpcr.2016.05.00165
Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, et al. Practices of infectious control management during neutropenia: A survey from 149 French hospitals. J Mycol Med 2017;27(2):227-31. doi:10.1016/j.mycmed.2017.02.006. Epub 2017 Mar 15. PMID: 28314678.
Moreira-Pinto J, Leão I, Palmela C, Branco F, Godinho J, Simões P, et al. Febrile neutropenia in patients with solid tumors undergoing intravenous chemotherapy. Oncol Res Treat 2020;43(11):605-12. doi:10.1159/000506109.
Innocenti R, Rigacci L, Restelli U, Giacomo S, Fanci R, Mannelli F, et al. Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey. J Blood Med 2018;10:21-7. doi:10.2147/JBM.S186786
Bryant AL, Walton A, Albrecht TA. Management of febrile neutropenia in a patient with acute leukemia. J Emerg Nurs 2014;40(4):377–81. doi:10.1016/j.jen.2013.07.021.